BACKGROUND: The potential association between fertility drugs and risk of ovarian cancer has been analysed using data from a case-control study conducted between January 1992 and September 1999 in four Italian areas. METHODS: Cases were 1031 women (median age 56, range 18-79 years) with incident, histologically confirmed epithelial ovarian cancer. Controls were 2411 women (median age 57, range 17-79 years) residing in the same geographical areas and admitted to the same network of hospitals for cases for a wide spectrum of acute, non neoplastic, non hormone-related conditions. RESULTS: A total of 15 cases and 26 controls reported use of fertility drugs. The corresponding odds ratio (OR) was 1.3 (95% confidence interval 0.7-2.5). The OR was 1.2 for women reporting last use < 25 years before interview and 1.3 for > 25 years. CONCLUSIONS: Considering calendar year at use, the OR was non-significantly above unity for women reporting fertility drug use after 1970, The OR was 0.6 among nulliparous women and 1.9 among parous ones.

Parazzini F, Pelucchi C, Negri E, Franceschi S, Talamini R, Montella M, et al. (2001). Use of fertility drugs and risk of ovarian cancer. HUMAN REPRODUCTION, 16(7), 1372-1375 [10.1093/humrep/16.7.1372].

Use of fertility drugs and risk of ovarian cancer

Negri E;
2001

Abstract

BACKGROUND: The potential association between fertility drugs and risk of ovarian cancer has been analysed using data from a case-control study conducted between January 1992 and September 1999 in four Italian areas. METHODS: Cases were 1031 women (median age 56, range 18-79 years) with incident, histologically confirmed epithelial ovarian cancer. Controls were 2411 women (median age 57, range 17-79 years) residing in the same geographical areas and admitted to the same network of hospitals for cases for a wide spectrum of acute, non neoplastic, non hormone-related conditions. RESULTS: A total of 15 cases and 26 controls reported use of fertility drugs. The corresponding odds ratio (OR) was 1.3 (95% confidence interval 0.7-2.5). The OR was 1.2 for women reporting last use < 25 years before interview and 1.3 for > 25 years. CONCLUSIONS: Considering calendar year at use, the OR was non-significantly above unity for women reporting fertility drug use after 1970, The OR was 0.6 among nulliparous women and 1.9 among parous ones.
2001
Parazzini F, Pelucchi C, Negri E, Franceschi S, Talamini R, Montella M, et al. (2001). Use of fertility drugs and risk of ovarian cancer. HUMAN REPRODUCTION, 16(7), 1372-1375 [10.1093/humrep/16.7.1372].
Parazzini F; Pelucchi C; Negri E; Franceschi S; Talamini R; Montella M; La Vecchia C
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/868156
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 48
social impact